We are live on ! Find out more
MCM

Mengis Capital Management Portfolio holdings

AUM $658M
1-Year Est. Return 39.64%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+39.64%
3 Year Est. Return
+91.78%
5 Year Est. Return
+129.93%
10 Year Est. Return
+407.15%
AUM
$363M
AUM Growth
+$27.4M
Cap. Flow
-$3.13M
Cap. Flow %
-0.86%
Top 10 Hldgs %
32.22%
Holding
170
New
6
Increased
42
Reduced
67
Closed
4

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.54M
2
DE icon
Deere & Co
DE
+$1.16M
3
DD icon
DuPont de Nemours
DD
+$631K
4
ABBV icon
AbbVie
ABBV
+$602K
5
OLED icon
Universal Display
OLED
+$566K

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Healthcare 16.9%
3 Industrials 15.75%
4 Consumer Staples 8.05%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALK icon
101
Alaska Air
ALK
$5.29B
$697K 0.19%
10,300
+100
+1% +$6.83K
USB.PRH icon
102
US Bancorp Series B Preferred Stock
USB.PRH
$748M
$683K 0.19%
31,785
-27
-0.1% -$583
ALC icon
103
Alcon
ALC
$33.6B
$657K 0.18%
11,615
+13
+0.1% +$745
UBER icon
104
Uber
UBER
$143B
$640K 0.18%
21,550
+10,550
+96% +$313K
ABBV icon
105
AbbVie
ABBV
$443B
$615K 0.17%
6,955
-7,250
-51% -$602K
MDT icon
106
Medtronic
MDT
$109B
$566K 0.16%
4,995
AGN
107
DELISTED
Allergan plc
AGN
$563K 0.16%
2,946
ABT icon
108
Abbott
ABT
$183B
$550K 0.15%
6,334
COLB icon
109
Columbia Banking Systems
COLB
$8.84B
$548K 0.15%
13,478
-1,120
-8% -$43.6K
IWM icon
110
iShares Russell 2000 ETF
IWM
$79.8B
$539K 0.15%
3,256
+11
+0.3% +$1.74K
JMF
111
DELISTED
NUVEEN ENERGY MLP TOTAL RETURN FUND
JMF
$513K 0.14%
66,128
-27,697
-30% -$214K
ORCL icon
112
Oracle
ORCL
$374B
$493K 0.14%
9,308
BA icon
113
Boeing
BA
$171B
$486K 0.13%
1,494
-110
-7% -$38.9K
SFIX
114
Stitch Fix
SFIX
$536M
$475K 0.13%
18,550
CMI icon
115
Cummins
CMI
$87.5B
$474K 0.13%
2,650
USB.PRO
116
DELISTED
U.S. BANCORP Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series H Non-Cum
USB.PRO
$471K 0.13%
18,168
-493
-3% -$12.6K
ROKU icon
117
Roku
ROKU
$21.5B
$457K 0.13%
3,420
+245
+8% +$33.7K
IVW icon
118
iShares S&P 500 Growth ETF
IVW
$73.8B
$445K 0.12%
9,200
SILK
119
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$405K 0.11%
+10,035
New +$351K
KMI icon
120
Kinder Morgan
KMI
$71.7B
$401K 0.11%
18,965
-9,147
-33% -$185K
DXJ icon
121
WisdomTree Japan Hedged Equity Fund
DXJ
$7.08B
$393K 0.11%
7,324
+329
+5% +$17.6K
BLK icon
122
Blackrock
BLK
$169B
$378K 0.1%
752
FNDX icon
123
Schwab Fundamental US Large Company Index ETF
FNDX
$26.7B
$377K 0.1%
26,550
-225
-0.8% -$3.07K
CSCO icon
124
Cisco
CSCO
$457B
$371K 0.1%
7,740
-50
-0.6% -$2.32K
MMP
125
DELISTED
Magellan Midstream Partners, L.P.
MMP
$370K 0.1%
5,900

Similar funds

Mengis Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Mengis Capital Management held 170 positions worth $363M, up 8.2% from $336M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Mengis Capital Management's Q4 2019 filing shows 6 new, 42 increased, 67 reduced and 4 closed positions. Its largest new stake was Silk Road Medical, Inc. Common Stock: 10,035 shares worth $405K. The largest sale was Celgene Corp, an estimated $2.54M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • Mengis Capital Management's largest Q4 2019 buy was Silk Road Medical, Inc. Common Stock: 10,035 shares worth $405K.
  • Mengis Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.23M increase.
  • Mengis Capital Management's biggest Q4 2019 reduction was Deere & Co, cutting an estimated $1.16M.
  • Mengis Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $2.54M.
  • Mengis Capital Management's ten largest holdings make up 32% of its $363M portfolio in Q4 2019.
  • Mengis Capital Management opened 6 new positions and closed 4 in Q4 2019.
  • Mengis Capital Management's portfolio value rose 8.2% quarter-over-quarter to $363M.

Based on Mengis Capital Management's 13F filing for Q4 2019, filed 6 Feb 2020.